IRIS UniCatt

Danese, Silvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.764
NA - Nord America 2.163
AS - Asia 932
SA - Sud America 150
AF - Africa 14
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.032
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.132
IT - Italia 1.376
DE - Germania 1.152
SE - Svezia 386
CN - Cina 381
SG - Singapore 307
UA - Ucraina 290
BR - Brasile 136
FR - Francia 132
IE - Irlanda 110
GB - Regno Unito 100
ID - Indonesia 65
FI - Finlandia 62
IN - India 50
RU - Federazione Russa 47
TR - Turchia 46
CA - Canada 20
NL - Olanda 18
JP - Giappone 17
KR - Corea 15
RO - Romania 13
HK - Hong Kong 12
IR - Iran 11
BE - Belgio 10
PL - Polonia 10
AT - Austria 9
ES - Italia 8
MX - Messico 7
CH - Svizzera 6
ZA - Sudafrica 6
LT - Lituania 5
AU - Australia 4
BD - Bangladesh 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
EU - Europa 4
AL - Albania 3
BZ - Belize 3
GR - Grecia 3
HR - Croazia 3
KE - Kenya 3
MA - Marocco 3
ME - Montenegro 3
PT - Portogallo 3
UZ - Uzbekistan 3
VN - Vietnam 3
AR - Argentina 2
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CO - Colombia 2
EE - Estonia 2
IL - Israele 2
KG - Kirghizistan 2
LK - Sri Lanka 2
PY - Paraguay 2
SA - Arabia Saudita 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
IQ - Iraq 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PK - Pakistan 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 7.032
Salva come PNG Salva come JPEG
Città #
Chandler 418
Singapore 201
Jacksonville 162
Ashburn 147
Milan 143
San Mateo 132
Rome 114
Dublin 108
Nanjing 80
Nürnberg 78
Wilmington 71
Jakarta 65
Ann Arbor 63
Dearborn 57
Boston 54
Princeton 46
Izmir 43
New York 41
Munich 40
Woodbridge 32
Nanchang 31
Redwood City 31
Moscow 30
Turin 29
Los Angeles 28
Palermo 27
Houston 25
Cattolica 22
Detroit 22
Seattle 22
Bremen 21
Frankfurt am Main 21
Hebei 20
Hefei 20
Marseille 20
Mountain View 20
Bologna 18
Bari 17
Lawrence 17
Shenyang 17
Fairfield 15
Kunming 15
University Park 15
Boardman 14
Changsha 14
Florence 14
Beijing 13
Genoa 13
Guangzhou 13
Hangzhou 12
Hong Kong 12
Jiaxing 12
Zhengzhou 12
Naples 11
Norwalk 11
Pune 11
Tianjin 11
Castignano 10
Seoul 10
Treviso 10
Udine 10
Andover 9
Belo Horizonte 9
Brussels 9
Catania 9
Augusta 8
Helsinki 8
Jinan 8
Leawood 8
Shanghai 8
Simi Valley 8
São Paulo 8
Toronto 8
Vienna 8
Dallas 7
Lancaster 7
Napoli 7
Parma 7
San Jose 7
Botosani 6
Costa Mesa 6
Düsseldorf 6
Garda 6
Kish 6
Lauterbourg 6
Nuremberg 6
Padova 6
Pavia 6
Redmond 6
Reggio Calabria 6
Roubaix 6
The Dalles 6
Torino 6
Verona 6
Buffalo 5
Caserta 5
Catanzaro 5
Chicago 5
Ferrara 5
Fremont 5
Totale 3.074
Salva come PNG Salva come JPEG
Nome #
Ruolo dei fattori psicologici nelle malattie infiammatorie croniche intestinali 1.523
A) Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease. 328
Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases. 211
-High prevalence of celiac disease in patients with lactose intolerance 187
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents 162
Early atherosclerosis in patients with inflammatory bowel disease. 147
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 147
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 144
Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in different populations. 137
-Increased carotid intima-media thickness in patients with inflammatory bowel disease 136
Pathophysiology, diagnosis and treatment of non-erosive reflux disease (NERD) 129
Intercellular adhesion molecule 1 gene polymorphisms in inflammatory bowel disease 128
Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria 121
Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradication 104
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? 103
-Extraintestinal manifestations in inflammatory Bowel disease. 100
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 100
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 98
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 96
A novel pathogenic role for microvasculature in inflammatory bowel disease. 94
Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients 94
Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. 92
A) Platelets: new players in the mucosal scenario of inflammatory bowel disease. 90
Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer. 90
Gender, chronic infection and myocardial infarction 87
Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events 84
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 81
Severe liver injury associated with zafirlukast 78
Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment 78
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 77
Biological therapies for inflammatory bowel disease: research drives clinics. 76
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 73
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 72
PAI-1 and TAFI in inflammatory bowel disease: the yin and yang of the fibrinolytic system. 71
Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statement 71
Balanced propofol sedation administered by nonanesthesiologists: The first Italian experience 70
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 68
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 68
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 67
Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment. 67
Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases 67
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial 67
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 64
-Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation 63
Elevated homocysteine levels in patients with Raynaud's syndrome 62
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 62
Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery 59
Inflammatory bowel diseases and psychological issues: A new approach for a systematic analysis of the academic debate 57
Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease 55
ag) CD40 antisense based strategy for inflammatory bowel disease: shutting down multiple cellular communication systems. 53
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. 53
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 51
Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting 50
Folate in gastrointestinal health and disease 48
A) CD40L-positive platelets induce CD40L expression de novo in endothelial cells: adding a loop to microvascular inflammation. 46
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease 46
Genetic and nutritional predictors of hyperhomocysteinemia in inflammatory bowel disease 45
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study 45
ag) Antibody to alpha4beta7 integrin for ulcerative colitis. 42
-Antibody to alpha4beta7 integrin for ulcerative colitis 41
Thrombotic complications in inflammatory bowel disease: a multifactorial etiology 39
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial 35
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study 34
Assessment of prothrombotic risk in patients with Behçet's disease should include homocysteine plasma levels 34
High prevalence of Helicobacter priori type I virulent strains in patients with systemic sclerosis [6] (multiple letters) 32
ag) Chemokines in inflammatory bowel disease. 30
Management of patients with complex perianal fistulas in Crohn's disease: Optimal patient flow in the Italian clinical reality 20
Efficacy and safety of Advanced Combination Treatment in immune-mediated inflammatory disease: A systematic review and meta-analysis of randomized controlled trials 17
Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer 16
Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease 14
Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis 13
Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease 5
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international study 1
Totale 7.115
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.236
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202066 0 0 0 0 0 0 0 0 0 0 0 66
2020/2021761 28 72 29 93 108 35 85 23 105 37 118 28
2021/2022689 48 66 19 49 32 18 17 127 27 38 113 135
2022/20231.309 146 164 101 202 95 156 66 117 154 26 42 40
2023/2024771 41 190 48 46 62 78 50 32 22 47 69 86
2024/20251.114 46 38 129 52 125 50 70 75 158 121 238 12
Totale 7.115